Buprenorphine And Naloxone 60687-0637
Product NDC
60687-0637- Manufacturer
- American Health Packaging
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- March 14, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA205601
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
| Naloxone Hydrochloride Dihydrate | 2 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Packaging Options(1)
50 BLISTER PACK in 1 CARTON (60687-637-65) / 1 TABLET in 1 BLISTER PACK (60687-637-11)